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INTRODUCTION
Preeclampsia is a pregnancy-specific syndrome,
which increases morbidity and mortality of both
mother and fetus, and it is responsible for 4-8% of
pregnancy complications. Based on the onset,
ACOG (American College of Obstetrics and Gyne-
cology) classified preeclampsia in two groups:
early onset preeclampsia for those occurred before
the 34th gestational week, and late onset pree-
clampsia for those occur after the 34th gestational
week.1 This classification is made according to the
significant differences in fetomaternal outcome of
both groups.1,2 Immunological, genetic, biochemi-
cal, and inflammatory factors are still discussed as
the underlying mechanisms of preeclampsia.3-5
Placental growth factor is pregnancy specific
hormone involved in trophoblastic invasion and fe-
tal growth. This hormone is first detected in the
fifth gestational week, the level of which keeps ris-
ing with placental growth. However, this does not
occur in pregnancy complicated by preeclampsia.6,7
PlGF level is a dependable marker to predict pre-
eclampsia.2, 8-10
Abstract
Objective: To analyze the difference of PlGF and TNF-α serum level
between early-onset and late-onset preeclampsia.
Method: This is a cross-sectional analytic comparative study com-
paring serum level of PlGF and TNF-α between groups with early-
and late-onset preeclampsia. Each group consists of 32 subjects who
met inclusion criteria and presented to Dr. Hasan Sadikin Hospital or
its district hospitals in September - November 2012. Statistical
analysis was performed with Kolmogorov Smirnov test, Saphiro-
Wilk test, and non-parametric Mann-Whitney test.
Result: Mean of PlGF serum level in the group with early-onset pree-
clampsia is 53.0344±38.07140 pg/ml, while mean of which in the
group with late-onset preeclampsia is 241.8063±192.8373 pg/ml
(p<0.0001). Mean of TNF-α serum level in the group with early-on-
set preeclampsia is 2.7733±0.97533pg/ml, while mean of which in
the group with late-onset preeclampsia is 2.5061±0.84872 pg/ml
(p= 0.235).
Conclusion: Serum level of PlGF in early-onset preeclampsia is
lower than the level of which in late-onset preeclampsia (p<0.0001).
There is no significant difference of TNF-α serum level between the
early- and late-onset preeclampsia (p=0.235).
[Indones J Obstet Gynecol 2012; 36-4: 181-4]
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Abstrak
Tujuan: Menganalisis perbedaan kadar PlGF dan TNF-α antara pre-
eklampsia awitan dini dan lambat.
Metode: Penelitian dilakukan dengan metode analitik komparatif
dengan metode potong lintang yang membandingkan kadar PlGF dan
TNF-α antara kelompok preeklampsia awitan dini dan lambat. Subjek
penelitian pada setiap kelompok berjumlah 32 pasien yang memenuhi
kriteria inklusi dan datang berobat ke RSUP Dr. Hasan Sadikin Ban-
dung serta rumah sakit jejaring yang ditunjuk pada bulan September
- November 2012. Analisis statistik dilakukan dengan uji Kolmogorov
Smirnov, uji Saphiro-Wilk, dan uji non-parametrik Mann-Whitney.
Hasil: Rerata PlGF serum pada kelompok preeklampsia awitan dini
adalah 53,0344±38,07140 pg/ml sedangkan pada kelompok preek-
lampsia awitan lambat adalah 241,8063±192,8373 pg/ml (p<0,0001).
Rerata TNF-α serum pada kelompok preeklampsia awitan dini adalah
2,7733±0,97533 pg/ml sedangkan pada kelompok preeklampsia awit-
an lambat adalah 2,5061±0,84872 pg/ml (p=0,235).
Kesimpulan: Kadar PlGF pada preeklampsia awitan dini lebih rendah
daripada preeklampsia awitan lambat (p<0,0001). Tidak ditemukan
perbedaan yang bermakna pada kadar TNF-α antara preeklampsia
awitan dini dan lambat (p=0,235).
[Maj Obstet Ginekol Indones 2012p; 36-4: 181-4]
Kata kunci: PlGF, preeklampsia awitan dini, preeklampsia awitan
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TNF-α induces vasoconstriction, and is involved
in micro vascular protein leakage and hypertri-
glyceridemia.11 Rise in TNF-α level is found in pa-
tients with preeclampsia.11-14
No study has reported comparison of angiogenic
factor (PlGF) and inflammatory factor (TNF-α) be-
tween early onset and late onset preeclampsia in
Indonesia. This is seen as an interesting topic, as
the result would bring us closer to understand
more about some factors to predict preeclampsia.
METHOD
This was a cross-sectional analytic comparative
study, comparing serum level of PlGF and TNF-α
between groups with early and late onset pree-
clampsia. Each group consisted of 32 subjects with
gestational age of 20 weeks or more, single live fe-
tus, who regularly have antenatal care, not showing
any signs of infection, and clinically diagnosed with
preeclampsia before and after the 34th gestational
week from the last menstrual period, not having
any history of hypertension nor kidney or liver dis-
order before pregnancy, and presented to Dr.
Hasan Sadikin Hospital or its district hospitals in
September - November 2012.
Five ml of blood sample were collected by cubi-
tal vein phlebotomy. The blood was stored for ±30
minutes in vacutainer, to be centrifuged in 3000
rpm thereafter for 10 minutes. The serum were
stored in plastic tubes at –20°C. Then the serum
level of PlGF and TNF-α were measured by ELISA
method. The results recorded were serum level of
PlGF in pg/ml and serum level of TNF-α in pg/ml.
RESULT
Characteristics of subjects in both groups are ana-
lyzed by Mann-Whitney test for numerical data and
Kolmogorov-Smirnov test for categorical data.
They are maternal age (in categories of <20 year
old, 20-35 year old, and >35 year old), parity (in
categories of 0, 1-3, and 4+), and BMI before preg-
nancy (with mean of 22.2538±1.19469 in subjects
with early-onset preeclampsia, and 23.1509±
1.90633 in those having late-onset preeclampsia).
Both groups do not show any significant difference
in maternal age (p=0.627), parity (p=1.000), or
BMI before pregnancy (p=0.073).
Saphiro-Wilk test for normality was done on the
PlGF and TNF-α serum level from the 64 subjects.
p value of <0.05 shows the data from both groups
are not normally distributed. Thus, the data was
analyzed with Mann-Whitney nonparametric test.
SPSS version 18.0 for windows was used in ana-
lyzing data.
Table 1. Comparison of PlGF serum level between early
onset and late onset preeclampsia
PlGF
serum level
(pg/ml)
Group
p
valueEarly onset pre
eclampsia (n=32)
Late onset pre
eclampsia (n=32)
Mean 53.0344 241.8063 <0.0001*
SD 38.07140 192.8373
Note: *Mann-Whitney test
Table 2. Comparison of TNF-a serum level between early-
onset and late-onset preeclampsia
TNF-α
serum level
(pg/ml)
Group
p
valueEarly onset pre
eclampsia (n=32)
Late onset pre
eclampsia (n=32)
Mean 2.7733 2.5061 0.235*
SD 0.97533 0.84872
Note: *Mann-Whitney test
Table 1 shows PlGF serum level of the group
with early-onset preeclampsia compared with late-
onset preeclampsia. The level is significantly lower
in the group with early onset preeclampsia.
Whereas Table 2 shows a nonsignificant result
(p>0.05), therefore TNF-α serum level of both
groups is not significantly different.
DISCUSSION
The two-stage model of preeclampsia proposes
that the first stage of preeclampsia is dominantly
caused by poorly perfused placentation. This con-
dition explains the lower PlGF level in the early on-
set compared with late onset preeclampsia, where
greater extent of placental damage takes place.15 A
study done by Ogge in 2011 explained that placen-
tal damage in early onset preeclampsia is his-
topathologically more extensive due to the greater
degree of lesion following the wider infarction, and
chronic inflammation such as vasculitis and villitis,
which causes decidual arteriopathy and further re-
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duction of villi surface volume. In early onset pre-
eclampsia, trophoblastic inadequate invasion to
maternal spiral artery accounts for reduced perfu-
sion to umbilical artery, which causes fetal restric-
tion.16 The significantly different level of PlGF
shown in this study may be affected by some fac-
tors, one of them is the very low level of which in
early onset preeclampsia may follow more damage
in placenta, although histopathological examina-
tion was not performed in this study. Furthermore,
the PlGF serum level in late onset preeclampsia is
higher, some approaching the level of which in nor-
mal pregnancy, because of the minimally damaged
or even intact placenta.2,16,17 Compared with the
other angiogenic factors, PlGF serum level is supe-
rior for detecting preeclampsia, as PlGF is placental
specific.15,18
This study reports a non-significant difference in
TNF-α serum level. This result can be explained by
theory of pathogenesis proposed by Roberts, in
which endothelial dysfunction following the in-
creased level of cytokine, such as TNF-α, is the sec-
ond stage of preeclampsia. Placental abnormalities
in the first stage may induce release of placental
factors into maternal circulation. This leads to
glomerular endotheliosis, vascular permeability,
and inflammatory response marked by increased
level of cytokines such as TNF-α, further causing
various organ damage by mechanism of hypoper-
fusion.15 According to former studies by Ogge and
Huppertz, placental abnormality in preeclampsia
may have occurred in the first trimester, even
when clinical manifestations are not observable
yet, leaving a more extensive placental damage.16,17
Earlier hypoxia condition happened in placenta
leads to earlier placental damage, thus cytokine ex-
pression ensues earlier. This is consistent with a
former study by Haider.5 Referring to the study by
Robert JM and Hubel CA in 2009, the second stage
of preeclampsia may occur even without the first
stage, when maternal risk factors such as obesity
and diabetes were clinically significant to generate
clinical manifestations of preeclampsia syndrome.15
Founds reported an enhancement of TNF-α pro-
duction by adipocytes in preeclamptic women.19
Further study including objective tests for kid-
ney and liver function in TNF-α measurement, or
investigating other factors to predict preeclampsia,
is encouraged.
CONCLUSION
Serum level of PlGF in early-onset preeclampsia is
lower than in late onset preeclampsia. There is no
significant difference of TNF-α serum level be-
tween the early and late onset preeclampsia.
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